| 2026-03-03 |
详情>>
股本变动：
变动后总股本96330.84万股
|
| 2026-03-03 |
详情>>
业绩披露：
2026年中报每股收益0.78美元,归母净利润7.54亿美元,同比去年增长0.66%
|
| 2026-02-19 |
财报披露：
美东时间 2026-02-19 盘后发布财报
|
| 2026-01-15 |
详情>>
内部人交易：
Liaw Jeffrey共交易6笔
|
| 2025-11-24 |
详情>>
业绩披露：
2026年一季报每股收益0.42美元,归母净利润4.04亿美元,同比去年增长11.50%
|
| 2025-10-24 |
股东大会：
将于2025-12-05召开股东大会
会议内容 ▼▲
- 1.To elect the twelve nominees for director named in this proxy statement to hold office until the 2026 annual meeting of stockholders or until their respective successors have been duly elected and qualified;
2.To approve, on an advisory (non-binding) basis, the compensation of our named executive officers for the fiscal year ended July 31, 2025;
3.To ratify the appointment by the Audit Committee of our Board of Directors of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending July 31, 2026;
4.To transact such other business as may properly come before the annual meeting or any adjournment or postponement of the annual meeting.
|
| 2025-09-26 |
详情>>
业绩披露：
2023年年报每股收益1.30美元,归母净利润12.38亿美元,同比去年增长13.54%
|
| 2025-09-26 |
详情>>
业绩披露：
2025年年报每股收益1.61美元,归母净利润15.52亿美元,同比去年增长13.90%
|
| 2025-06-03 |
详情>>
业绩披露：
2025年三季报(累计)每股收益1.20美元,归母净利润11.56亿美元,同比去年增长11.11%
|
| 2025-02-26 |
详情>>
业绩披露：
2025年中报每股收益0.78美元,归母净利润7.49亿美元,同比去年增长13.88%
|
| 2024-11-26 |
详情>>
业绩披露：
2024年一季报每股收益0.35美元,归母净利润3.33亿美元,同比去年增长35.26%
|
| 2024-11-26 |
详情>>
业绩披露：
2025年一季报每股收益0.38美元,归母净利润3.62亿美元,同比去年增长8.89%
|
| 2024-10-24 |
股东大会：
将于2024-12-06召开股东大会
会议内容 ▼▲
- 1.To elect the twelve nominees for director named in this proxy statement to hold office until our 2025 annual meeting of stockholders or until their respective successors have been duly elected and qualified.
2.To approve, on an advisory (non-binding) basis, the compensation of our named executive officers for the fiscal year ended July 31, 2024.
3.To ratify the appointment by the Audit Committee of our Board of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending July 31, 2025.
4.To transact such other business as may properly come before the annual meeting or any adjournment or postponement of the annual meeting.
|
| 2024-09-30 |
详情>>
业绩披露：
2024年年报每股收益1.42美元,归母净利润13.63亿美元,同比去年增长10.12%
|
| 2024-05-23 |
详情>>
业绩披露：
2024年三季报(累计)每股收益1.08美元,归母净利润10.40亿美元,同比去年增长16.91%
|
| 2024-02-27 |
详情>>
业绩披露：
2024年中报每股收益0.69美元,归母净利润6.58亿美元,同比去年增长21.99%
|
| 2023-10-26 |
股东大会：
将于2023-12-08召开股东大会
会议内容 ▼▲
- 1.To elect the eleven nominees for director named in the proxy statement to hold office until our 2024 annual meeting of stockholders or until their respective successors have been duly elected and qualified;
2.To approve, on an advisory (non-binding) basis, the compensation of our named executive officers for the fiscal year ended July 31, 2023;
3.To approve, on an advisory (non-binding) basis, the frequency of a stockholder advisory vote on executive compensation;
4.To ratify the appointment by the Audit Committee of our Board of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending July 31, 2024;
5.To transact such other business as may properly come before the annual meeting or any adjournment or postponement of the annual meeting.
|
| 2023-08-22 |
详情>>
拆分方案：
每1.0000股拆分成2.0000股
|
| 2022-11-02 |
股东大会：
将于2022-12-02召开股东大会
会议内容 ▼▲
- 1.To elect the eleven nominees for director named in the proxy statement to hold office until our 2023 annual meeting of stockholders or until their respective successors have been duly elected and qualified;
2.To approve, on an advisory (non-binding) basis, the compensation of our named executive officers for the fiscal year ended July 31, 2022;
3.To ratify the appointment by the audit committee of our board of directors of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending July 31, 2023;
4.To transact such other business as may properly come before the annual meeting or any adjournment or postponement of the annual meeting.
|
| 2022-10-13 |
股东大会：
将于2022-10-31召开股东大会
会议内容 ▼▲
- 1.To approve an amendment and restatement of the Company’s Certificate of Incorporation to (i) increase the number of shares of our common stock authorized for issuance from 400,000,000 shares to 1,600,000,000 shares, primarily to facilitate a 2-for-1 split of the Company’s common stock in the form of a stock dividend, and (ii) make certain other changes as set forth in Appendix A attached to the proxy statement accompanying this notice of special meeting of stockholders (the “Authorized Share Increase Proposal”).
2.To authorize the adjournment of the special meeting, if necessary, to solicit additional proxies if there are insufficient votes in favor of the Authorized Share Increase Proposal.
3.Any other matter that properly comes before the special meeting or any adjournment or postponement thereof.
|
| 2022-10-05 |
详情>>
拆分方案：
每1.0000股拆分成2.0000股
|
| 2021-10-22 |
股东大会：
将于2021-12-03召开股东大会
会议内容 ▼▲
- 1.To elect the eleven nominees for director named in this proxy statement to hold office until our 2022 annual meeting of stockholders or until their respective successors have been duly elected and qualified.
2.To approve, on an advisory (non-binding) basis, the compensation of our named executive officers for the fiscal year ended July 31, 2021.
3.To ratify the appointment by the audit committee of our board of directors of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending July 31, 2022.
4.To transact such other business as may properly come before the annual meeting or any adjournment or postponement of the annual meeting.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2020-11-02 |
股东大会：
将于2020-12-04召开股东大会
会议内容 ▼▲
- 1.To elect the nine nominees for director named in the proxy statement to hold office until our 2021 annual meeting of stockholders or until their respective successors have been duly elected and qualified;
2.To approve, on an advisory (non-binding) basis, the compensation of our named executive officers for the fiscal year ended July 31, 2020;
3.To approve an amendment to our amended and restated 2007 Equity Incentive Plan to increase the number of shares reserved under the plan from 32,000,000 shares to 36,000,000 shares;
4.To ratify the appointment by the audit committee of our board of directors of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending July 31, 2021;
5.To transact such other business as may properly come before the annual meeting or any adjournment or postponement of the annual meeting.
|
| 2019-11-04 |
股东大会：
将于2019-12-06召开股东大会
会议内容 ▼▲
- 1.To elect the nine nominees for director named in the proxy statement to hold office until our 2020 annual meeting of stockholders or until their respective successors have been duly elected and qualified;
2.To approve, on an advisory (non-binding) basis, the compensation of our named executive officers for the fiscal year ended July 31, 2019;
3.To ratify the appointment by the audit committee of our board of directors of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending July 31, 2020;
4.To transact such other business as may properly come before the annual meeting or any adjournment or postponement of the annual meeting.
|
| 2018-11-16 |
股东大会：
将于2018-12-17召开股东大会
会议内容 ▼▲
- 1.To elect the seven nominees for director named in the proxy statement to hold office until our 2019 annual meeting of stockholders or until their respective successors have been duly elected and qualified;
2.To approve, on an advisory (non-binding) basis, the compensation of our named executive officers for the fiscal year ended July 31, 2018;
3.To ratify a cash and equity director compensation program for our executive chairman and non-employee directors;
4.To ratify the appointment by the audit committee of our board of directors of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending July 31, 2019;
5.To approve adjournment of the meeting to a later date or dates, if necessary or desirable, to permit further solicitation and vote of proxies, in the event there are not sufficient votes to approve one or more of the above proposals;
6.To transact such other business as may properly come before the annual meeting or any adjournment or postponement of the annual meeting.
|
| 2017-11-06 |
股东大会：
将于2017-12-08召开股东大会
会议内容 ▼▲
- 1. To elect the eight nominees for director named in the proxy statement to hold office until our 2018 annual meeting of stockholders or until their respective successors have been duly elected and qualified;
2. To approve, on an advisory (non-binding) basis, the compensation of our named executive officers for the fiscal year ended July 31, 2017;
3. To approve, on an advisory (non-binding) basis, the frequency of a stockholder advisory vote on executive compensation;
4. To ratify the appointment by the audit committee of our board of directors of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending July 31, 2018;
5. To transact such other business as may properly come before the annual meeting or any adjournment or postponement of the annual meeting.
|
| 2017-03-24 |
详情>>
拆分方案：
每1.0000股拆分成2.0000股
|
| 2016-11-14 |
股东大会：
将于2016-12-16召开股东大会
会议内容 ▼▲
- 1. To elect the eight nominees for director named in the proxy statement to hold office until our 2017 annual meeting of stockholders or until their respective successors have been duly elected and qualified;
2. To approve the amendment to and restatement of our 2007 Equity Incentive Plan, including amendments to increase the number of shares reserved under the plan from 12,000,000 shares to 16,000,000 and to extend the term of the plan through 2026;
3. To approve an amendment to our Certificate of Incorporation to remove the provision providing for cumulative voting by stockholders for the election of members of our Board;
4. To approve, on an advisory (non-binding) basis, the compensation of our named executive officers for the fiscal year ended July 31, 2016;
5. To ratify the appointment by the audit committee of our board of directors of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending July 31, 2017;
6. To transact such other business as may properly come before the annual meeting or any adjournment or postponement of the annual meeting.
|
| 2015-11-03 |
股东大会：
将于2015-12-02召开股东大会
会议内容 ▼▲
- 1.To elect the eight nominees for director named in the proxy statement to hold office until our 2016 annual meeting of stockholders or until their respective successors have been duly elected and qualified;
2.To approve an amendment to our certificate of incorporation to increase the maximum number of authorized shares of our common stock, from 180,000,000 authorized shares to 400,000,000 authorized shares;
3.To approve, on an advisory (non-binding) basis, the compensation of our named executive officers for the fiscal year ended July 31, 2015;
4.To ratify the appointment by the audit committee of our board of directors of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending July 31, 2016;
5.To transact such other business as may properly come before the annual meeting or any adjournment or postponement of the annual meeting.
|